Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

      Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

      Medical Dialogues Bureau23 Sept 2019 10:15 AM IST
      "At the conclusion of the inspection, we received a Form 483 with four observations for the new Drug Substance facility, three observations for the...
      Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

      Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

      Medical Dialogues Bureau23 Sept 2019 10:00 AM IST
      Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
      Cipla API facility in Bengaluru gets EIR from USFDA

      Cipla API facility in Bengaluru gets EIR from USFDA

      Medical Dialogues Bureau23 Sept 2019 9:45 AM IST
      Cipla had earlier said that USFDA issued seven observations after conducting a routine 'CGMP inspection' at Cipla's API manufacturing facility in...
      Torrent Pharma expands recall of Losartan tablets in US over carcinogen impurity

      Torrent Pharma expands recall of Losartan tablets in US over carcinogen impurity

      Medical Dialogues Bureau23 Sept 2019 9:00 AM IST
      "The recall is expanded to include an additional three lots of Losartan potassium tablets USP and 2 lots of Losartan potassium/hydrochlorothiazide...
      CDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing Surveillance on atleast 200 patients

      CDSCO directs makers of Aceclofenac, Drotaverine Hydrochloride FDC to conduct Active Post Marketing Surveillance on atleast 200 patients

      Medical Dialogues Bureau22 Sept 2019 11:30 AM IST
      New Delhi: Through a recent notification, the Central Drugs Standard Control Organisation(CDSCO) has directed all the manufacturers of Fixed-Dose...
      Unichem Labs API facility in Kolhapur clears CGMP surveillance by USFDA

      Unichem Labs API facility in Kolhapur clears CGMP surveillance by USFDA

      Medical Dialogues Bureau22 Sept 2019 10:00 AM IST
      New Delhi: Drug firm Unichem Laboratories recently said the US health regulator has concluded inspection of its new facility at Kolhapur, Maharashtra...
      Cipla arm, Novartis enter agreement for Ultibro Breezhaler to treat COPD

      Cipla arm, Novartis enter agreement for Ultibro Breezhaler to treat COPD

      Medical Dialogues Bureau22 Sept 2019 9:45 AM IST
      This partnership will enable Cipla arm (Breathe Free Lanka) to facilitate easy access to Ultibro Breezhaler for patients in Sri Lanka to help them...
      Siemens Healthineers invests Rs 20 crore for medical imaging manufacturing facility at Bengaluru

      Siemens Healthineers invests Rs 20 crore for medical imaging manufacturing facility at Bengaluru

      Medical Dialogues Bureau22 Sept 2019 9:30 AM IST
      Siemens Healthineers has made a Rs 20-crore investment in a new manufacturing facility collocated with its RnD centre at Bengaluru.New Delhi: Medical...
      Condom sales down by 8 percent, estimates Industry sources

      Condom sales down by 8 percent, estimates Industry sources

      Medical Dialogues Bureau22 Sept 2019 9:15 AM IST
      Industry sources estimated condom sales are down 8% since the start of the year compared to 2018 and have fallen by a quarter over recent months.New...
      Lupin gets USFDA nod for generic equivalent of UNITHROID to treat thyroid

      Lupin gets USFDA nod for generic equivalent of UNITHROID to treat thyroid

      Medical Dialogues Bureau21 Sept 2019 11:22 AM IST
      Lupin Ltd’s Levothyroxine Sodium Tablets USP, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200 mcg, and 300...
      AstraZeneca, Ironwood Pharma amend IBS-C drug deal in China

      AstraZeneca, Ironwood Pharma amend IBS-C drug deal in China

      Medical Dialogues Bureau21 Sept 2019 9:30 AM IST
      The amended agreement gives AstraZeneca sole responsibility for developing, manufacturing and commercialising Linzess in China mainland, China Hong...
      Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

      Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

      Medical Dialogues Bureau21 Sept 2019 9:30 AM IST
      "We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,"...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok